Follow
Frank Porreca
Frank Porreca
Professor of Pharmacology, University of Arizona
Verified email at medadmin.arizona.edu
Title
Cited by
Cited by
Year
Opioid analgesics and antagonists
JH Jaffe
The pharmacological basis of therapeutics, 485-521, 1991
21121991
Central modulation of pain
MH Ossipov, GO Dussor, F Porreca
The Journal of clinical investigation 120 (11), 3779-3787, 2010
13962010
Chronic pain and medullary descending facilitation
F Porreca, MH Ossipov, GF Gebhart
Trends in neurosciences 25 (6), 319-325, 2002
11552002
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
C Wahlestedt, P Salmi, L Good, J Kela, T Johnsson, T Hökfelt, ...
Proceedings of the National Academy of Sciences 97 (10), 5633-5638, 2000
8672000
Descending pain modulation and chronification of pain
MH Ossipov, K Morimura, F Porreca
Current opinion in supportive and palliative care 8 (2), 143-151, 2014
8192014
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
MM Ibrahim, F Porreca, J Lai, PJ Albrecht, FL Rice, A Khodorova, G Davar, ...
Proceedings of the National Academy of Sciences 102 (8), 3093-3098, 2005
6732005
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
MM Ibrahim, H Deng, A Zvonok, DA Cockayne, J Kwan, HP Mata, ...
Proceedings of the National Academy of Sciences 100 (18), 10529-10533, 2003
6062003
Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1. 8
J Lai, MS Gold, CS Kim, D Biana, MH Ossipov, JC Hunterc, F Porreca
Pain 95 (1-2), 143-152, 2002
5972002
Unmasking the tonic-aversive state in neuropathic pain
T King, L Vera-Portocarrero, T Gutierrez, TW Vanderah, G Dussor, J Lai, ...
Nature neuroscience 12 (11), 1364-1366, 2009
5892009
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
F Porreca, HI Mosberg, R Hurst, VJ Hruby, TF Burks
Journal of Pharmacology and Experimental Therapeutics 230 (2), 341-348, 1984
5461984
CB2 cannabinoid receptor-mediated peripheral antinociception
TP Malan Jr, MM Ibrahim, H Deng, Q Liu, HP Mata, T Vanderah, F Porreca, ...
Pain 93 (3), 239-245, 2001
5112001
A newly identified role for superoxide in inflammatory pain
ZQ Wang, F Porreca, S Cuzzocrea, K Galen, R Lightfoot, E Masini, ...
Journal of Pharmacology and Experimental Therapeutics 309 (3), 869-878, 2004
4892004
Statistical analysis of drug-drug and site-site interactions with isobolograms
RJ Tallarida, F Porreca, A Cowan
Life sciences 45 (11), 947-961, 1989
4851989
Redistribution of NaV1. 8 in uninjured axons enables neuropathic pain
MS Gold, D Weinreich, CS Kim, R Wang, J Treanor, F Porreca, J Lai
Journal of Neuroscience 23 (1), 158-166, 2003
4682003
Reward and motivation in pain and pain relief
E Navratilova, F Porreca
Nature neuroscience 17 (10), 1304-1312, 2014
4672014
The rat paw formalin test: comparison of noxious agents
H Wheeler-Aceto, F Porreca, A Cowan
Pain 40 (2), 229-238, 1990
4551990
The role of sodium channels in chronic inflammatory and neuropathic pain
R Amir, CE Argoff, GJ Bennett, TR Cummins, ME Durieux, P Gerner, ...
The Journal of Pain 7 (5), S1-S29, 2006
4412006
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2, 3-dihydrobenzo [b][1, 4] dioxin-6-yl) acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties
NR Gavva, R Tamir, Y Qu, L Klionsky, TJ Zhang, D Immke, J Wang, D Zhu, ...
Journal of Pharmacology and Experimental Therapeutics 313 (1), 474-484, 2005
4392005
Voltage-gated sodium channels and hyperalgesia
J Lai, F Porreca, JC Hunter, MS Gold
Annu. Rev. Pharmacol. Toxicol. 44, 371-397, 2004
4312004
Molecular determinants of vanilloid sensitivity in TRPV1
NR Gavva, L Klionsky, Y Qu, L Shi, R Tamir, S Edenson, TJ Zhang, ...
Journal of biological chemistry 279 (19), 20283-20295, 2004
4242004
The system can't perform the operation now. Try again later.
Articles 1–20